# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4372253 | B | Inhibition of recombinant 6His-Tev-tagged LRRK2 (1326 to 2527) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-RLGRDKYKTLRQIRQGNTKQR-OH as substrate preincubated for 30 mins followed by substrate addition and measured after 2 hrs by TR-FRET assay | Homo sapiens | 26 | ALA4371037 | cell-based format | Scientific Literature | |
2. | ALA4372254 | P | Lipophilicity, log D of the compound at pH 7.4 by chromatographic method | 26 | ALA4371037 | small-molecule physicochemical format | Scientific Literature | ||
3. | ALA4372255 | P | Kinetic solubility of the compound | 26 | ALA4371037 | small-molecule physicochemical format | Scientific Literature | ||
4. | ALA4372256 | A | Intrinsic clearance in human liver microsomes | Homo sapiens | 20 | ALA4371037 | microsome format | Scientific Literature | |
5. | ALA4372257 | A | Ratio of permeability across apical to basolateral side in MDCK2-MDR1 cells transduced with BacMam2-BCRP in presence of P-gp inhibitor GF120918 to absence of GF120918 | Canis lupus familiaris | 15 | ALA4371037 | cell-based format | Scientific Literature | |
6. | ALA4372258 | A | Passive permeability across apical to basolateral side in MDCK2-MDR1 cells transduced with BacMam2-BCRP at 3 uM after 90 mins in presence of P-gp inhibitor GF120918 by Transwell assay | Canis lupus familiaris | 15 | ALA4371037 | cell-based format | Scientific Literature | |
7. | ALA4372261 | B | Inhibition of parkinson's patient-derived LRRK2 G2019S mutant | Homo sapiens | 2 | ALA4371037 | single protein format | Scientific Literature | |
8. | ALA4372262 | B | Inhibition of human lymphoblastoid cell-derived LRRK2 | Homo sapiens | 2 | ALA4371037 | single protein format | Scientific Literature | |
9. | ALA4372263 | B | Inhibition of MKK1 (unknown origin) at 1 uM by radioactivity-based assay relative to control | Homo sapiens | 1 | ALA4371037 | single protein format | Scientific Literature | |
10. | ALA4372265 | A | Fraction unbound in rat blood | Rattus norvegicus | 2 | ALA4371037 | tissue-based format | Scientific Literature | |
11. | ALA4372266 | A | Fraction unbound in rat brain | Rattus norvegicus | 2 | ALA4371037 | tissue-based format | Scientific Literature | |
12. | ALA4372267 | A | Binding affinity to human serum albumin assessed as unbound fraction | Homo sapiens | 2 | ALA4371037 | single protein format | Scientific Literature | |
13. | ALA4372268 | A | Inhibition of human CYP3A4 using atorvastatin as substrate | Homo sapiens | 2 | ALA4371037 | single protein format | Scientific Literature | |
14. | ALA4372269 | A | Activation of human PXR | Homo sapiens | 2 | ALA4371037 | single protein format | Scientific Literature | |
15. | ALA4372270 | A | Inhibition of OATP1B1 (unknown origin) | Homo sapiens | 2 | ALA4371037 | single protein format | Scientific Literature | |
16. | ALA4372271 | B | Inhibition of human ERG by IonWork assay | Homo sapiens | 2 | ALA4371037 | single protein format | Scientific Literature | |
17. | ALA4372272 | F | In vivo inhibition of LRRK2 phosphorylation at Ser935 residue in naive rat brain at 5 mg/kg, iv administered as bolus dose followed by 5 ml/kg/hr iv infusion for 4 hrs by Western blot analysis relative to control | Rattus norvegicus | 1 | ALA4371037 | organism-based format | Scientific Literature | |
18. | ALA4372273 | F | In vivo inhibition of LRRK2 phosphorylation at Ser935 residue in naive rat kidney at 5 mg/kg, iv administered as bolus dose followed by 5 ml/kg/hr iv infusion for 4 hrs by Western blot analysis relative to control | Rattus norvegicus | 1 | ALA4371037 | organism-based format | Scientific Literature | |
19. | ALA4372274 | F | In vivo inhibition of LRRK2 phosphorylation at Ser935 residue in naive rat spleen at 5 mg/kg, iv administered as bolus dose followed by 5 ml/kg/hr iv infusion for 4 hrs by Western blot analysis relative to control | Rattus norvegicus | 1 | ALA4371037 | organism-based format | Scientific Literature | |
20. | ALA4372275 | A | Drug level in naive rat blood at 5 mg/kg, iv administered as bolus dose followed by 5 ml/kg/hr iv infusion for 4 hrs | Rattus norvegicus | 1 | ALA4371037 | organism-based format | Scientific Literature |